An orally bioavailable small molecule antagonist of VISTA and VSIG8 signaling pathways shows potent anti-tumor activity

被引：0
|
作者：
Sasikumar, Pottayil [1 ]
Naremaddepalli, Sudarshan [1 ]
Ramachandra, Raghuveer [1 ]
Gowda, Nagesh [1 ]
Alluri, Govardhan [1 ]
Yerramsetti, Manikyalarao [1 ]
Adurthi, Sreenivas [1 ]
Mani, Jiju [1 ]
Nair, Rashmi [1 ]
Dhudashiya, Amit [1 ]
Dodheri, Samiulla [1 ]
Gowda, Nagaraj [1 ]
Ramachandra, Murali [1 ]
机构：
[1] Aurigene Discovery Technol Ltd, Bangalore, Karnataka, India
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P354
引用
收藏
页数：1
相关论文
共 50 条
  • [1] An orally bioavailable small molecule antagonist of TIM-3 signaling pathway shows potent anti-tumor activity
    Sasikumar, Pottayil G.
    Naremaddepalli, Sudarshan S.
    Ramachandra, Raghuveer K.
    Gowda, Nagesh
    Devarapalli, Srinivaskumar
    Adurthi, Sreenivas
    Mani, Jiju
    Nair, Rashmi
    Dhudashiya, Amit A.
    Samiulla, Dodheri S.
    Gowda, Nagaraj M.
    Ramachandra, Murali
    CANCER RESEARCH, 2019, 79 (13)
  • [2] CB-708, an orally bioavailable small molecule inhibitor of CD73 with immunostimulatory and anti-tumor activity
    Lee, Clarissa
    Bhupathi, Deepthi
    Billedeau, Roland
    Chen, Jason
    Chen, Lijing
    Dang, Rosalyn
    Gross, Matthew
    Huang, Tony
    Li, Weiqun
    Ma, Yong
    MacKinnon, Andrew
    Marguier, Gisele
    Neou, Silinda
    Parlati, Francesco
    Sotirovska, Natalija
    Spurlock, Sandra
    Stanton, Timothy
    Steggerda, Susanne
    Zhang, Jing
    Zhang, Winter
    Li, Jim
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [3] Potent anti-tumor activity of a selective and orally bioavailable reversible covalent CDK12 inhibitor
    Khare, Leena
    Poddutoori, Ramulu
    Mukherjee, Subhendu
    Samiulla, D. S.
    Devaraja, T. S.
    Marappan, Sivapriya
    Nayak, Shilpa
    Sivakumar, Sasirekha
    Kaza, Lakshmi
    Tgore, Suraj
    Dhudashiya, Amit
    Raghavendra, N. R.
    Gunnepalli, Bhargav
    Aravind, A. B.
    Amith, A.
    Charamanna, K. B.
    Antony, Thomas
    Nellore, Kavitha
    Daginakatte, Girish
    Chelur, Shekar
    Giri, Sanjeev
    Ramachandra, Murali
    Samajdar, Susanta
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [4] Anti-tumor activity of orally bioavailable inhibitors of the 20S proteasome
    Demo, S.
    Aujay, A. N.
    Bennett, M. K.
    Dajee, M. P.
    Fang, R. Y.
    Goldstein, E. R.
    Jiang, J.
    Ho, M. N.
    Laidig, G. J.
    Lewis, E. R.
    Lu, Y.
    Muchamuel, T. M.
    Sehl, L. C.
    Shenk, K. D.
    Shwonek, P. J.
    Stanton, T. F.
    Sun, C. M.
    Sylvain, C.
    Woo, T. M.
    Yang, J.
    Zhou, H.
    Kirk, C. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 275 - 276
  • [5] Discovery of novel potent and orally bioavailable small-molecule inhibitors of ENPP1 to stabilize cGAMP and ATP in the tumor microenvironment and boost anti-tumor immunity.
    Versele, Matthias
    Garcia, Javier del Pino
    Vandecaetsbeek, Ilse
    Castermans, Karolien
    Kellens, Ranie
    Haeck, Wanda
    Klaassen, Hugo
    Bourin, Arnaud
    De Clercq, Dries
    Allasia, Sara
    Boland, Sandro
    Marchand, Arnaud
    Chaltin, Patrick
    Bollen, Mathieu
    CANCER RESEARCH, 2021, 81 (13)
  • [6] HJM-353: A potent, selective and orally bioavailable EED inhibitor with robust anti-tumor activities
    Ma, X.
    Qi, W.
    Du, Y.
    Kong, D.
    Geng, Y.
    Zeng, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1122 - S1122
  • [7] Novel Selective Orally Bioavailable Small Molecule PAK4 Allosteric Modulators (PAMs) Display Anti-Tumor Activity in Vitro and in Vivo in Hematological Malignancies
    Senapedis, William
    George, Ryan
    McCauley, Dilara
    Ellis, Joel
    Crochiere, Marsha
    Savona, Michael
    Shacham, Sharon
    Landesman, Yosef
    Baloglu, Erkan
    BLOOD, 2014, 124 (21)
  • [8] Discovery of highly potent, selective, and orally bioavailable IKZF2 degrader and its anti-tumor activity in syngeneic mouse models
    Park, Seulki
    Moon, Jeong Hee
    Lee, Gaseul
    Kim, Hyun Jin
    Kim, Jeong-Hoon
    Hwang, Jong Yeon
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Artesunate shows potent anti-tumor activity in B-cell lymphoma
    Thea Kristin Våtsveen
    Marit Renée Myhre
    Chloé Beate Steen
    Sébastien Wälchli
    Ole Christian Lingjærde
    Baoyan Bai
    Pierre Dillard
    Theodossis A. Theodossiou
    Toril Holien
    Anders Sundan
    Else Marit Inderberg
    Erlend B. Smeland
    June Helen Myklebust
    Morten P. Oksvold
    Journal of Hematology & Oncology, 11
  • [10] Artesunate shows potent anti-tumor activity in B-cell lymphoma
    Vatsveen, Thea Kristin
    Myhre, Marit Renee
    Steen, Chloe Beate
    Walchli, Sebastien
    Lingjaerde, Ole Christian
    Bai, Baoyan
    Dillard, Pierre
    Theodossiou, Theodossis A.
    Holien, Toril
    Sundan, Anders
    Inderberg, Else Marit
    Smeland, Erlend B.
    Myklebust, June Helen
    Oksvold, Morten P.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
12345